Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.43 |
| ▸ | CNR1 | P21554 | 10/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18374177 | 0.90 | CNR2 (0.51) | CNR2CNR1SLC6A3LMNAKDM4E | |
| SCHEMBL22958896 | 0.87 | CNR2 (0.52) | CNR2CNR1SLC6A3ALDH1A1 | |
| SCHEMBL18255590 | 0.82 | CNR2 (0.50) | CNR2CNR1SLC6A3ALDH1A1 | |
| SCHEMBL27589737 | 0.81 | CNR2 (0.58) | CNR2CNR1SLC6A3LMNAKDM4E | |
| SCHEMBL22958846 | 0.80 | KDM4E (0.41) | CNR2CNR1ALDH1A1LMNAKDM4E | |
| SCHEMBL19362900 | 0.77 | CNR2 (0.51) | CNR2CNR1SLC6A3CA2ALDH1A1 | |
| SCHEMBL29031145 | 0.77 | CNR2 (0.54) | CNR2CNR1SLC6A3LMNAKDM4E | |
| SCHEMBL18942462 | 0.73 | PADI4 (0.41) | CNR2CNR1SLC6A3ALDH1A1 | |
| SCHEMBL17067960 | 0.72 | KMT2A (0.45) | ALDH1A1LMNAKDM4E | |
| SCHEMBL29666216 | 0.70 | BACE1 (0.49) | CA2ALDH1A1CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017210542-A1 | CROSS-GENERA TARGET GENOME CAPTURE AND ANALYSIS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2017-12-07 | — | — | WO | disclosed |